SEC Form 4 · accession 0001237899-15-000049
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Powchik
Officer — SVP Clinical Development & Reg
Period of report
Aug 13, 2015
Accepted (ET)
Aug 17, 2015 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 13, 2015 | M | 10,000 | $270.43 | A | 25,821 | D | |
| Common Stock | Aug 13, 2015 | F | 4,667 | $579.35 | D | 21,154 | D | |
| Common Stock | Aug 13, 2015 | F | 2,749 | $579.35 | D | 18,405 | D | |
| Common Stock | Aug 13, 2015 | M | 14,625 | $179.13 | A | 33,030 | D | |
| Common Stock | Aug 13, 2015 | F | 4,521 | $579.35 | D | 28,509 | D | |
| Common Stock | Aug 13, 2015 | F | 5,210 | $579.35 | D | 23,299 | D | |
| Common Stock | Aug 13, 2015 | M | 23,000 | $52.03 | A | 46,299 | D | |
| Common Stock | Aug 13, 2015 | F | 2,065 | $579.35 | D | 44,234 | D | |
| Common Stock | Aug 13, 2015 | F | 10,795 | $579.35 | D | 33,439 | D | |
| Common Stock | Aug 13, 2015 | M | 8,000 | $52.03 | A | 41,439 | D | |
| Common Stock | Aug 13, 2015 | F | 718 | $579.35 | D | 40,721 | D | |
| Common Stock | Aug 13, 2015 | F | 3,755 | $579.35 | D | 36,966 | D | |
| Common Stock | Aug 13, 2015 | M | 4,736 | $30.63 | A | 41,702 | D | |
| Common Stock | Aug 13, 2015 | F | 250 | $579.35 | D | 41,452 | D | |
| Common Stock | Aug 13, 2015 | F | 2,146 | $579.35 | D | 39,306 | D | |
| Common StockF1 | Aug 14, 2015 | S | 1,405 | $569.63 | D | 37,901 | D | |
| Common StockF2 | Aug 14, 2015 | S | 3,603 | $570.63 | D | 34,298 | D | |
| Common StockF3 | Aug 14, 2015 | S | 5,598 | $571.54 | D | 28,700 | D | |
| Common StockF4 | Aug 14, 2015 | S | 2,800 | $572.60 | D | 25,900 | D | |
| Common StockF5 | Aug 14, 2015 | S | 2,717 | $573.64 | D | 23,183 | D | |
| Common StockF6 | Aug 14, 2015 | S | 900 | $574.75 | D | 22,283 | D | |
| Common StockF7 | Aug 14, 2015 | S | 700 | $575.47 | D | 21,583 | D | |
| Common StockF8 | Aug 14, 2015 | S | 2,004 | $576.65 | D | 19,579 | D | |
| Common StockF9 | Aug 14, 2015 | S | 2,258 | $577.75 | D | 17,321 | D | |
| Common StockF10 | Aug 14, 2015 | S | 1,500 | $578.63 | D | 15,821 | D | |
| Common Stock | holding | — | — | — | 12,890 | I | by GRAT | |
| Common Stock | holding | — | — | — | 1,652 | I | By 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F11 | $30.63 | Aug 13, 2015 | M | 4,736 | D | — | Dec 14, 2020 | Common Stock | 4,736 | 0 | D |
| Non-Qualified Stock Option (right to buy)F12 | $52.03 | Aug 13, 2015 | M | 23,000 | D | — | Dec 16, 2021 | Common Stock | 23,000 | 14,079 | D |
| Non-Qualified Stock Option (right to buy)F11 | $52.03 | Aug 13, 2015 | M | 8,000 | D | — | Dec 16, 2021 | Common Stock | 8,000 | 6,079 | D |
| Non-Qualified Stock Option (right to buy)F13 | $179.13 | Aug 13, 2015 | M | 14,625 | D | — | Dec 14, 2022 | Common Stock | 14,625 | 29,250 | D |
| Non-Qualified Stock Option (right to buy)F13 | $270.43 | Aug 13, 2015 | M | 10,000 | D | — | Dec 13, 2023 | Common Stock | 10,000 | 30,000 | D |
Explanation of responses
- F1Represents volume-weighted average price of sales of 1,405 shares of Company stock on August 14, 2015 at prices ranging from $569.11 to $570.09. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
- F10Represents volume-weighted average price of sales of 1,500 shares of Company stock on August 14, 2015 at prices ranging from $578.14 to $579.07. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
- F11The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- F12The option became exercisable with respect to all shares underlying the option on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014.
- F13The stock option award vests in four equal annual installments, commencing one year after the date of grant.
- F2Represents volume-weighted average price of sales of 3,603 shares of Company stock on August 14, 2015 at prices ranging from $570.15 to $571.09. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
- F3Represents volume-weighted average price of sales of 5,598 shares of Company stock on August 14, 2015 at prices ranging from $571.14 to $572.01. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
- F4Represents volume-weighted average price of sales of 2,800 shares of Company stock on August 14, 2015 at prices ranging from $572.23 to $573.06. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
- F5Represents volume-weighted average price of sales of 2,717 shares of Company stock on August 14, 2015 at prices ranging from $573.15 to $574.09. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
- F6Represents volume-weighted average price of sales of 900 shares of Company stock on August 14, 2015 at prices ranging from $574.20 to $575.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
- F7Represents volume-weighted average price of sales of 700 shares of Company stock on August 14, 2015 at prices ranging from $575.30 to $576.04. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
- F8Represents volume-weighted average price of sales of 2,004 shares of Company stock on August 14, 2015 at prices ranging from $576.16 to $577.09. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.
- F9Represents volume-weighted average price of sales of 2,258 shares of Company stock on August 14, 2015 at prices ranging from $577.24 to $578.08. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2015 at each separate price.